Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants

Attentional Bias Modification Treatment (ABMT) as Adjuvant Therapy for Anxiety Disorder Patients Resistent to Antidepressants: A Randomized Clinical Trial

The objective of this project is to test the combination of active or placebo Attentional Bias Modification Treatment (ABMT) to usual treatment for anxiety disorder patients resistant to antidepressants.

Inclusion Criteria:

• Primary diagnosis of Generalized Anxiety Disorder, Panic Disorder or Social Anxiety Disorder according to the International Neuropsychiatric Interview psychiatric interview (M.I.N.I.)
• Current treatment for the anxiety disorder with antidepressants with an appropriate dose for at least 8 weeks;
• Score on OASIS (Overall Anxiety Severity and Impairment Scale)equal or greater than 8

Exclusion Criteria:

• Other psychiatric disorder that causes more impairment and suffering than generalized anxiety disorder, panic disorder or social anxiety disorder in the clinical evaluation
• Current Cognitive Behavior Therapy
• Marked intellectual disability (clinically evident)
• Suicidal ideation or suicide plan at the time of assessment(M.I.N.I.)
• Psychotic disorder (M.I.N.I.)
• Bipolar disorder type I (M.I.N.I.)
• Abuse / Dependence substances (M.I.N.I.)